Popular Weight-Loss Drug May Treat Obstructive Sleep Apnea: New Study

Published on June 21, 2024

Tirzepatide, a popular antidiabetic drug approved for chronic weight management, may also aid in treating obstructive sleep apnea (OSA) in obese patients, according to new research funded by the drug’s manufacturer, Eli Lilly and Company.  Obstructive sleep apnea is a common breathing disorder affecting the upper airways. It causes people to experience breathing interruptions during sleep, resulting in impaired sleep quality, mental health problems, and an increased risk of cardiovascular disease. Tirzepatide, branded as Mounjaro and Zepbound, reduced sleeping patients’ breathing interruptions by almost 59 percent, according to the research paper published Friday in the New England Journal of Medicine (NEJM)....

Continue reading on website
Other news

22 Charged in Drug Ring Bust That Netted 12,900 Pounds of Meth

June 21, 2024
Twenty-two people have been indicted by a federal grand jury in Fresno, California, over alleged smuggling of more than 12,000 pounds of methamphetamine and dozens of pounds of fentanyl, cocaine, and heroin from Mexico, prosecutors announced this week.The drug smuggling ring is accused of stashing liquid, powder, and pill versions of the drugs inside portable projectors, batteries, semi-trucks and

We Are at the Beginning of an AI Revolution: Expert Raises Concerns

June 21, 2024
As the reach of artificial intelligence (AI) expands and AI is being added into items from toothbrushes to cars, regulation and oversight has been out of sync with the speed of development.Companies are turning to AI for productivity and efficiency, saying that it can conduct tasks more accurately, faster, and cheaper than humans. This has led to many layoffs in Silicon Valley, but job loss is not